Healthcare burden and factors of type 2 diabetes mellitus with Schizophrenia
- PMID: 33860331
- DOI: 10.1007/s00406-021-01258-8
Healthcare burden and factors of type 2 diabetes mellitus with Schizophrenia
Abstract
This study investigated healthcare utilization and expenditure for patients with type 2 diabetes mellitus and schizophrenia and associated factors. Healthcare utilization (outpatient visits and hospitalization) and expenditure (outpatient, inpatient, and total medical expenditure) between 2002 and 2013 of patients with T2DM with schizophrenia (case group) and without (control group) were examined using the Taiwan National Health Insurance Research Database. (1) The average total numbers of outpatient visits and hospital admissions of the case group were 35.14 outpatient visits and 1.09 hospital admissions significantly higher than those of the control group in the whole study period (based on every 3-year period). Nonpsychiatric outpatient visits and nonpsychiatric hospital admissions were significantly more numerous for the case group. (2) The total outpatient expenditure, total inpatient expenditure, and total medical expenditure of the case group were NT$65,000, NT$170,000, and NT$235,000 significantly higher than those of the control group, respectively. Nonpsychiatric outpatient expenditure was significantly lower for the case group, but the inpatient and total nonpsychiatric medical expenditure were similar between groups. (3) Patients who were elder of low income, with complications, and high diabetes mellitus complication severity index had higher total numbers of outpatient visits and hospitalizations and medical expenditure. (4) Women had a higher number of outpatient visits but a lower number of hospitalization and medical expenditure. Lower non-psychiatric outpatient expenditure despite more visits indicated non-psychiatrist may not understand schizophrenia patients and cannot communicate well with them, leading to neglect of medical evaluation and treatment that should be carried out.
Keywords: Expenditure; Healthcare utilization; Schizophrenia; Type 2 diabetes mellitus.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Healthcare Utilization and Its Correlates in Comorbid Type 2 Diabetes Mellitus and Generalized Anxiety Disorder.Psychiatr Q. 2024 Jun;95(2):233-252. doi: 10.1007/s11126-024-10072-z. Epub 2024 Apr 19. Psychiatr Q. 2024. PMID: 38639873
-
A longitudinal study of healthcare utilisation and expenditure in people with type 2 diabetes mellitus with and without major depressive disorder.Gen Hosp Psychiatry. 2019 Mar-Apr;57:50-58. doi: 10.1016/j.genhosppsych.2018.09.007. Epub 2018 Oct 30. Gen Hosp Psychiatry. 2019. PMID: 30908962
-
Healthcare Utilization and Expenditures for Persons with Diabetes Comorbid with Mental Illnesses.Psychiatr Q. 2016 Sep;87(3):545-57. doi: 10.1007/s11126-015-9408-9. Psychiatr Q. 2016. PMID: 26646577
-
Health care utilization and expenditures of persons with diabetes comorbid with anxiety disorder: a national population-based cohort study.Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):299-304. doi: 10.1016/j.genhosppsych.2015.04.008. Epub 2015 Apr 16. Gen Hosp Psychiatry. 2015. PMID: 25936674
-
Associations between participation in a diabetes pay-for-performance program and health outcomes and healthcare utilization among people with comorbid schizophrenia and type 2 diabetes in Taiwan.Gen Hosp Psychiatry. 2025 May-Jun;94:99-107. doi: 10.1016/j.genhosppsych.2025.02.025. Epub 2025 Mar 2. Gen Hosp Psychiatry. 2025. PMID: 40043624
Cited by
-
The impact of comorbid severe mental illness and common chronic physical health conditions on hospitalisation: A systematic review and meta-analysis.PLoS One. 2022 Aug 18;17(8):e0272498. doi: 10.1371/journal.pone.0272498. eCollection 2022. PLoS One. 2022. PMID: 35980891 Free PMC article.
-
Relationship between eating attitudes, depression, and insight in schizophrenic patients with and without type 2 diabetes mellitus: a comparative study in Guangdong, China.Front Psychiatry. 2024 Oct 3;15:1477953. doi: 10.3389/fpsyt.2024.1477953. eCollection 2024. Front Psychiatry. 2024. PMID: 39421064 Free PMC article.
References
-
- Suvisaari J, Keinanen J, Eskelinen S, Mantere O (2016) Diabetes and schizophrenia. Curr Diab Rep 16:16 - PubMed
-
- Laursen TM, Munk-Olsen T, Vestergaard M (2012) Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatry 25:83–88 - PubMed
-
- Pedersen CB, Mors O, Bertelsen A et al (2014) A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiat 71:573–581
-
- Perälä J, Suvisaari J, Saarni SI et al (2007) Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 64:19–28 - PubMed
-
- Kovacs G, Almasi T, Millier A et al (2018) Direct healthcare cost of schizophrenia—European overview. Eur Psychiatry 48:79–92 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials